MétaCan
Menu
Back to cohort
Record W4415104073 · doi:10.1016/j.clon.2025.103944

The Use of Molecular Tools for Identifying and Guiding Treatment of Cancers of Unknown Primary: A Systematic Review

2025· article· en· W4415104073 on OpenAlexafffund
Samuel D. Saibil, Xiaomei Yao, Duvaraga Sivajohanathan, Marisa Deodat, Michael M. Vickers, Paul Wheatley‐Price, Juyong Yoon, Harriet Feilotter

Bibliographic record

VenueClinical Oncology · 2025
Typearticle
Languageen
FieldMedicine
TopicCancer Diagnosis and Treatment
Canadian institutionsUniversity Health NetworkPrincess Margaret Cancer CentreOttawa HospitalCancer Care OntarioQueen's UniversityJuravinski Cancer Centre
FundersMinistry of Health, Ontario
KeywordsProfiling (computer programming)ImmunotherapyTargeted therapySystematic reviewMEDLINEOverall survival

Abstract

fetched live from OpenAlex

BACKGROUND: Cancer of unknown primary (CUP) represents a significant clinical challenge due to its heterogeneity and the poor prognosis often associated with the disease. Molecular profiling has emerged as a promising approach to address the challenges associated with CUP. This systematic review evaluates the existing evidence on the value of different types of molecular tools for CUP diagnosis and treatment. METHODS: MEDLINE, EMBASE and Cochrane Database of Systematic Reviews published between 2013 and 2024 were searched for shortlisting eligible studies, relating to the use of molecular profiling tests in clinical management of CUP patients. Eight studies are included in this review. RESULTS: Among 1556 publications from the literature search, four randomized controlled trials (RCTs), one comparative study, two single-arm studies reporting comparative data, and one diagnostic study were included. The certainty of the aggregate evidence ranged from low to very low for the studies, as assessed by the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) approach. Studies using contemporary methods to determine tumour of origin or tumour agnostic actionable mutations demonstrated the positive impact on survival of CUP patients with access to targeted therapy and immunotherapy. CONCLUSIONS: This systematic review highlights the complexities of the existing literature in patients with CUP. The published impact of molecular profiling tools on survival outcomes by guiding treatment has been limited due to study design; however, improved survival has been shown in patients who have received immunotherapy or targeted therapy. The results from future RCTs or high-quality comparative studies will clarify the role of molecular profiling tools in patients with CUP.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.009
metaresearch head score (Gemma)0.047
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Systematic review · Consensus signal: Systematic review
GenreCandidate signal: Review · Consensus signal: Review
Teacher disagreement score0.009
Threshold uncertainty score0.049

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0090.047
Meta-epidemiology (narrow)0.0010.001
Meta-epidemiology (broad)0.0060.009
Bibliometrics0.0060.006
Science and technology studies0.0000.001
Scholarly communication0.0020.002
Open science0.0020.001
Research integrity0.0020.001
Insufficient payload (model declined to judge)0.0020.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.367
GPT teacher head0.512
Teacher spread0.145 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designSystematic review
Domainnot available
GenreReview

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2025
Admission routes2
Has abstractno

Explore more

Same venueClinical OncologySame topicCancer Diagnosis and TreatmentFrench-language works237,207